CGM Beats Finger Sticks for Type 2 Diabetes on Basal Insulin

What Was Studied and Why It Matters

Millions of people with type 2 diabetes take basal insulin — a long-acting insulin dose taken once or twice daily to control blood sugar levels overnight and between meals. Most of these patients check their blood sugar using traditional finger-stick meters. But researchers wanted to know: would switching to a continuous glucose monitor (CGM) — a small sensor worn on the skin that reads blood sugar every few minutes — produce faster, better results?

The MOBILE study enrolled 175 adults with type 2 diabetes on basal insulin and randomly assigned them to either use a real-time CGM device or continue with standard finger-stick blood glucose monitoring (BGM) for 3 months. This analysis focused specifically on how quickly improvements appeared.

What the Researchers Found

The results were clear and meaningful. After just 3 months:

• A1C dropped more with CGM: The CGM group's average A1C fell from 9.1% down to 8.0% — a full 1.1-point drop. The finger-stick group only dropped from 9.0% to 8.5%. That half-point difference may sound small, but it translates to meaningfully lower risk of long-term complications.
• More time in a healthy blood sugar range: CGM users spent about 9% more of their day with blood sugar in the ideal range of 70–180 mg/dL compared to finger-stick users.
• Less time with dangerously high blood sugar: CGM users spent nearly 6% less time with blood sugar above 250 mg/dL — a level that raises the risk of serious complications.
• Fewer low blood sugar episodes: Despite the tighter control, CGM users actually had fewer hypoglycemic (low blood sugar) events per week — not more. This is an important safety win.
• Improvements started within the first week: Patients using CGM saw meaningful changes in their blood sugar patterns within just 7 days of starting — a remarkably fast response.

What This Means for Real Patients

If you manage type 2 diabetes with basal insulin, this research suggests that upgrading from a traditional finger-stick meter to a continuous glucose monitor could help you get your blood sugar under control faster — and more safely. CGMs give you and your care team a much richer picture of how your blood sugar moves throughout the day, making it easier to adjust your insulin dose and daily habits.

Many popular CGM sensors, along with the lancets, test strips, and other diabetes supplies you may still need, are available through MDS Diabetes — a trusted source for diabetes management products delivered to your door.

Bottom Line

In adults with type 2 diabetes using basal insulin, switching from finger-stick monitoring to a continuous glucose monitor produced significantly lower A1C levels, more time in a healthy blood sugar range, and fewer dangerous lows — all within just 3 months, with improvements beginning in the very first week. Talk to your doctor about whether a CGM could be the right next step for your diabetes care.